Filing Details
- Accession Number:
- 0000899243-17-010932
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-26 21:00:35
- Reporting Period:
- 2017-04-24
- Filing Date:
- 2017-04-26
- Accepted Time:
- 2017-04-26 21:00:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1590877 | Regenxbio Inc. | RGNX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1202285 | Jr J Donald Hayden | C/O Regenxbio Inc. 9600 Blackwell Road, Suite 210 Rockville MD 20850 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-04-24 | 10,000 | $20.98 | 28,599 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $20.45 to $21.425. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.